ArticleCancers2026

Basal-like Phenotype Identifies Immunotherapy-Responsive Subset of HR+/HER2- Breast Cancer with Aggressive Clinical Behavior.

Fangyu He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.